| Financial Year |
March 31 2023 |
| Monetary Funds |
101,544,082.66 |
| Held-for-trading Financial Assets |
469,000,000.00 |
| Notes Receivable |
809,386.32 |
| Accounts Receivable |
161,735,610.58 |
| Advances to Suppliers |
2,930,768.24 |
| Other Receivables |
30,427,900.04 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
95,625.00 |
| Dividend Receivable |
-- |
| Inventories |
150,120,548.87 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
5,324,191.22 |
| Total Current Assets |
926,339,475.53 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
8,438,712.25 |
| Investment Properties |
46,132,281.64 |
| Fixed Assetes |
43,417,888.71 |
| Under-construction Projects |
517,337.74 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
22,534,778.63 |
| R&D expenses |
-- |
| Goodwill |
6,216,392.25 |
| Long-Term Deferred and Prepaid Expenses |
1,465,591.66 |
| Deferred Income Tax Assets |
6,357,968.79 |
| Other Non-Current Assets |
97,628,661.61 |
| Sub-Total of Non-Current Assets |
430,023,696.11 |
| Total Assets |
1,356,363,171.64 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
50,917,115.20 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
8,749,511.60 |
| Taxes Payable |
5,779,941.64 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
7,267,461.40 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,141,154.22 |
| Other Current Liabilities |
2,651,688.97 |
| Sub-Total of Current Liabilities |
118,156,907.44 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
2,800,000.00 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
4,085,085.34 |
| Total Liabilities |
122,241,992.78 |
| Paid-In Capital(Or Share Stock) |
480,831,536.00 |
| Capital Surplus |
595,026,076.78 |
| Surplus Reserve |
48,370,223.77 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
77,619,215.95 |
| Minority Stockholder's Interest |
32,274,126.36 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,201,847,052.50 |
| Owner's Equity（Stockholder's Equity） |
1,234,121,178.86 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,356,363,171.64 |
